---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-081674"
form_type: "8-K"
ticker: "AGEN"
cik: "0001098972"
company_name: "AGENUS INC"
filed_at: "2025-06-04T23:59:59+00:00"
generated_at: "2026-05-19T23:34:17.567140+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Agenus sells manufacturing assets to Zydus for $75M upfront; license BOT/BAL in India

## Summary
- Asset sale of Emeryville/ Berkeley CA facilities for $75M at closing; up to $50M additional contingent payments.
- Exclusive license to Zydus for BOT/BAL in India and Sri Lanka; 5% royalty on net sales.
- Zydus makes $16M equity investment at $7.50/share (approx. 2.1M shares); 12-month lockup.
- Transaction includes contract manufacturing agreement; proceeds to fund BOT/BAL development.
- Parties aim to close within 60 days, subject to customary conditions and government approvals.

## SEC filing metadata
- accession: 0000950170-25-081674
- form_type: 8-K
- ticker: AGEN
- cik: 0001098972
- company_name: AGENUS INC
- filed_at: 2025-06-04T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1098972/000095017025081674/0000950170-25-081674-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1098972/000095017025081674/agen-20250603.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-081674
- JSON: https://secwatch.observer/filing/0000950170-25-081674.json
- Plain text: https://secwatch.observer/filing/0000950170-25-081674.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.